Jean-Michel Molina Selected Research

Jean-Michel Molina Research Topics

Disease

62	Infections 05/2024 - 04/2005
35	HIV Infections (HIV Infection) 03/2023 - 01/2003
15	Acquired Immunodeficiency Syndrome (AIDS) 03/2023 - 12/2003
14	Sexually Transmitted Diseases (Sexually Transmitted Disease) 03/2024 - 11/2005
11	Tuberculosis (Tuberculoses) 03/2024 - 07/2008
10	Viremia 01/2022 - 11/2005
9	Coinfection 01/2022 - 04/2011
7	Exanthema (Rash) 01/2021 - 11/2009
6	Hepatitis B 11/2023 - 11/2015
5	Headache (Headaches) 05/2024 - 04/2015
5	COVID-19 01/2024 - 12/2020
5	Dizziness (Lightheadedness) 01/2019 - 07/2011
5	Chronic Hepatitis C 01/2017 - 07/2010
5	Lipodystrophy 01/2011 - 03/2002
4	Immune Reconstitution Inflammatory Syndrome 03/2024 - 07/2008
4	Syphilis 11/2023 - 11/2018
4	Hepatitis 01/2023 - 04/2010
4	Microsporidiosis 01/2021 - 06/2002
4	Nausea 01/2020 - 08/2008
4	Fibrosis (Cirrhosis) 03/2016 - 02/2006
4	Liver Cirrhosis (Hepatic Cirrhosis) 12/2015 - 02/2006
3	Weight Gain 02/2024 - 01/2020
3	Pneumonia (Pneumonitis) 01/2024 - 01/2022
3	Inflammation (Inflammations) 03/2021 - 02/2020
3	Diarrhea 01/2006 - 06/2002
2	Gonorrhea 01/2023 - 11/2018
2	Hepatitis A (Hepatitis, Infectious) 01/2023 - 03/2012
2	Lymphoma (Lymphomas) 04/2022 - 12/2003
2	Disease Progression 01/2022 - 01/2021
2	Communicable Diseases (Infectious Diseases) 01/2022 - 01/2020
2	Glioblastoma (Glioblastoma Multiforme) 01/2019 - 06/2005
2	Neoplasms (Cancer) 01/2019 - 06/2010
2	Hepatitis C 01/2016 - 04/2011
2	Anemia 01/2016 - 12/2014
2	Renal Insufficiency (Renal Failure) 08/2013 - 04/2003

Drug/Important Bio-Agent (IBA)

28	RNA (Ribonucleic Acid)IBA 12/2022 - 04/2005
22	Tenofovir (Viread)FDA Link 11/2023 - 04/2003
21	Emtricitabine (Emtriva)FDA Link 11/2023 - 04/2005
17	Raltegravir Potassium FDA Link 10/2023 - 10/2009
17	efavirenz (Sustiva)FDA Link 10/2023 - 02/2006
12	Ritonavir (Norvir)FDA Link 01/2020 - 04/2007
11	Antiviral Agents (Antivirals)IBA 01/2023 - 04/2005
10	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 05/2003
9	RacivirIBA 11/2023 - 05/2012
9	NucleosidesIBA 01/2022 - 03/2002
8	doravirineIBA 05/2024 - 01/2018
8	Doxycycline (Periostat)FDA LinkGeneric 02/2024 - 03/2012
8	LipidsIBA 12/2023 - 01/2007
7	Ribavirin (Virazole)FDA LinkGeneric 01/2017 - 07/2010
6	VaccinesIBA 03/2024 - 03/2012
6	AntibodiesIBA 11/2023 - 05/2003
6	Lamivudine (Epivir)FDA Link 01/2022 - 06/2014
6	Protease Inhibitors (Protease Inhibitor)IBA 01/2022 - 06/2005
6	Rilpivirine (TMC-278)IBA 09/2020 - 07/2011
6	tenofovir alafenamideIBA 01/2020 - 01/2017
6	Atazanavir Sulfate (Reyataz)FDA Link 03/2014 - 08/2008
5	elvitegravirIBA 01/2023 - 04/2013
5	TabletsIBA 12/2022 - 03/2014
5	Darunavir (Prezista)FDA Link 01/2020 - 04/2007
4	Anti-Bacterial Agents (Antibiotics)IBA 03/2024 - 05/2003
4	CreatinineIBA 12/2023 - 04/2003
4	CobicistatIBA 01/2023 - 04/2013
4	Reverse Transcriptase InhibitorsIBA 01/2022 - 01/2007
4	Biomarkers (Surrogate Marker)IBA 01/2021 - 06/2009
4	AntigensIBA 01/2021 - 01/2015
4	abacavir (Ziagen)FDA Link 01/2018 - 02/2008
4	InterferonsIBA 03/2015 - 07/2010
4	Enfuvirtide (Fuzeon)FDA Link 09/2011 - 10/2009
3	islatravirIBA 05/2024 - 01/2021
3	dolutegravirIBA 01/2022 - 04/2015
3	Integrase InhibitorsIBA 02/2020 - 03/2011
3	daclatasvirIBA 01/2017 - 09/2015
3	Lopinavir FDA Link 01/2015 - 08/2008
3	HLA-B Antigens (HLA-B)IBA 09/2013 - 02/2008
3	Glucose (Dextrose)FDA LinkGeneric 01/2011 - 12/2003
2	Azithromycin (Zithromax)FDA LinkGeneric 01/2023 - 10/2021
2	Illicit Drugs (Recreational Drugs)IBA 01/2023 - 01/2022
2	IntegrasesIBA 01/2022 - 03/2011
2	Rifampin (Rifampicin)FDA LinkGeneric 01/2022 - 01/2021
2	fumagillinIBA 01/2021 - 06/2002
2	EnzymesIBA 01/2021 - 01/2019
2	cobicistat mixture with darunavirIBA 01/2019 - 01/2018
2	bictegravirIBA 01/2018 - 01/2018
2	Immunoglobulin G (IgG)IBA 03/2017 - 04/2012
2	SofosbuvirIBA 01/2017 - 03/2015
2	N- (3- amino- 1- (cyclobutylmethyl)- 2,3- dioxopropyl)- 3- (2- ((((1,1- dimethylethyl)amino)carbonyl)amino)- 3,3- dimethyl- 1- oxobutyl)- 6,6- dimethyl- 3- azabicyclo(3.1.0)hexan- 2- carboxamideIBA 03/2016 - 01/2016
2	N- (8- aminohexyl)- 5- iodonaphthalene- 1- sulfonamide (W8)IBA 03/2016 - 01/2016
2	BilirubinIBA 01/2014 - 08/2008

Therapy/Procedure

50	Therapeutics 10/2023 - 03/2002
14	Highly Active Antiretroviral Therapy (HAART) 03/2017 - 11/2005
8	Art Therapy 03/2024 - 01/2012
7	Condoms (Condom) 03/2024 - 12/2015
3	Duration of Therapy 01/2022 - 07/2010
3	Hematopoietic Stem Cell Transplantation 01/2022 - 09/2007
2	Stem Cell Transplantation 04/2022 - 09/2007
2	Aftercare (After-Treatment) 01/2022 - 01/2017
2	Transplantation 04/2021 - 04/2014
2	Injections 09/2020 - 04/2005
2	Drug Therapy (Chemotherapy) 04/2015 - 12/2003
2	Blood Transfusion (Blood Transfusions) 12/2014 - 11/2008